Pharmacokinetics of Oral Acetylcysteine: Absorption, Binding and Metabolism in Patients with Respiratory Disorders
The fate of an oral 100mg dose of 35S-acetylcysteine, a mucolytic agent, was studied in 10 patients with respiratory disorders, 5 of whom underwent pneumonectomy or lobectomy a few hours after administration of the drug. In the 5 nonoperated patients, plasma radioactivity concentrations were maximal after 2 to 3 hours and remained high after 24 hours: about 22% of radioactivity was excreted in urine after 24 hours. In the 5 operated patients, plasma radioactivity concentrations were comparable with those in the nonoperated patients. Lung tissue radioactivity concentrations after 5 hours were comparable with those in plasma, while the presence of small amounts of radioactivity in the bronchial secretions indicates that acetylcysteine passes into the mucus.
Total radioactivity after 5 hours consisted of free, unchanged drug and metabolites (about 22% of total in plasma, 48% in lung tissue), unchanged drug bound to protein by means of labile disulphide bridges (about 14% in plasma, 47% in lung tissue), and drug firmly bound to protein (about 64% in plasma, 5% in lung tissue).
Oral acetylcysteine is rapidly absorbed and slowly excreted and is available in the lung in an active form for at least 5 hours at high concentrations.
KeywordsLung Tissue Total Radioactivity Unchanged Drug Radioactivity Concentration Acetylcysteine
Unable to display preview. Download preview PDF.
- Gazzaniga, A.; Borgogelli, E.; Giulidori, P.; Maneoni, G.; Martinetti, M. and Milan, C.: Pharmacokinetics and metabolism of 35S labelled N-acetyl-L-cysteine, Part I. Unpublished report prepared by Zambon SpA Research Laboratories, Bresso, Milan, Italy (1975).Google Scholar
- Gazzaniga, A.; Borgogelli, E.; Giulidori, P.; Martinetti, M. and Milan, C.: Pharmacokinetics and Metabolism of 35S labelled N-acetyl-L-cysteine, Part 2. Unpublished report prepared by Zambon SpA Research Laboratories, Bresso, Milan, Italy (1976).Google Scholar
- Fawell, J.K.: Autoradiography of 35S N-acetyl-L-cysteine. Unpublished report by Inveresk Research International, Scotland (1976).Google Scholar
- Porsio, A. and Borgia, M.: Esperienze cliniche di attivita e tollerabilita con l’acetilcisteina per via orale. Assorbimento del Tiamfenicolo dal Tiamfenicolo Glicinato Acetilcisteinato. Clinica Terapeutica 64: 341–356 (1973).Google Scholar
- Sheffner, L.A.: The mucolytic activity, mechanism of action and metabolism of acetylcysteine. Pharmakotherapia 1: 47 (1965).Google Scholar